FDA Import Refusal 799-4131113-7/11/1 — NOVO NORDISK
The FDA refused shipment 799-4131113-7/11/1 from NOVO NORDISK (Canada) on Dec 5, 2024. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charges: 118,3280,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Dec 5, 2024
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61PCL72 SEMAGLUTIDE (ANTI-DIABETIC)
- Charges
- 118,3280,75